Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting
Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial...
Ausführliche Beschreibung
Autor*in: |
McHugh, R. Kathryn [verfasserIn] |
---|
Format: |
E-Artikel |
---|---|
Sprache: |
Englisch |
Erschienen: |
2014transfer abstract |
---|
Umfang: |
9 |
---|
Übergeordnetes Werk: |
Enthalten in: Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study - González, W. ELSEVIER, 2016, Amsterdam [u.a.] |
---|---|
Übergeordnetes Werk: |
volume:45 ; year:2014 ; number:2 ; pages:232-240 ; extent:9 |
Links: |
---|
DOI / URN: |
10.1016/j.beth.2013.11.002 |
---|
Katalog-ID: |
ELV034204075 |
---|
LEADER | 01000caa a22002652 4500 | ||
---|---|---|---|
001 | ELV034204075 | ||
003 | DE-627 | ||
005 | 20230625200208.0 | ||
007 | cr uuu---uuuuu | ||
008 | 180603s2014 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.beth.2013.11.002 |2 doi | |
028 | 5 | 2 | |a GBVA2014019000028.pica |
035 | |a (DE-627)ELV034204075 | ||
035 | |a (ELSEVIER)S0005-7894(13)00103-2 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
082 | 0 | |a 150 |a 610 | |
082 | 0 | 4 | |a 150 |q DE-600 |
082 | 0 | 4 | |a 610 |q DE-600 |
082 | 0 | 4 | |a 540 |q VZ |
084 | |a 35.21 |2 bkl | ||
100 | 1 | |a McHugh, R. Kathryn |e verfasserin |4 aut | |
245 | 1 | 0 | |a Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
264 | 1 | |c 2014transfer abstract | |
300 | |a 9 | ||
336 | |a nicht spezifiziert |b zzz |2 rdacontent | ||
337 | |a nicht spezifiziert |b z |2 rdamedia | ||
338 | |a nicht spezifiziert |b zu |2 rdacarrier | ||
520 | |a Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. | ||
520 | |a Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. | ||
700 | 1 | |a Kertz, Sarah J. |4 oth | |
700 | 1 | |a Weiss, Rachel B. |4 oth | |
700 | 1 | |a Baskin-Sommers, Arielle R. |4 oth | |
700 | 1 | |a Hearon, Bridget A. |4 oth | |
700 | 1 | |a Björgvinsson, Thröstur |4 oth | |
773 | 0 | 8 | |i Enthalten in |n Elsevier |a González, W. ELSEVIER |t Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |d 2016 |g Amsterdam [u.a.] |w (DE-627)ELV014436809 |
773 | 1 | 8 | |g volume:45 |g year:2014 |g number:2 |g pages:232-240 |g extent:9 |
856 | 4 | 0 | |u https://doi.org/10.1016/j.beth.2013.11.002 |3 Volltext |
912 | |a GBV_USEFLAG_U | ||
912 | |a GBV_ELV | ||
912 | |a SYSFLAG_U | ||
912 | |a SSG-OLC-PHA | ||
912 | |a GBV_ILN_22 | ||
912 | |a GBV_ILN_40 | ||
912 | |a GBV_ILN_73 | ||
936 | b | k | |a 35.21 |j Lösungen |j Flüssigkeiten |x Physikalische Chemie |q VZ |
951 | |a AR | ||
952 | |d 45 |j 2014 |e 2 |h 232-240 |g 9 | ||
953 | |2 045F |a 150 |
author_variant |
r k m rk rkm |
---|---|
matchkey_str |
mchughrkathrynkertzsarahjweissrachelbbas:2014----:hneidsrsitlrnentetetucmiaat |
hierarchy_sort_str |
2014transfer abstract |
bklnumber |
35.21 |
publishDate |
2014 |
allfields |
10.1016/j.beth.2013.11.002 doi GBVA2014019000028.pica (DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 DE-627 ger DE-627 rakwb eng 150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl McHugh, R. Kathryn verfasserin aut Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting 2014transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Kertz, Sarah J. oth Weiss, Rachel B. oth Baskin-Sommers, Arielle R. oth Hearon, Bridget A. oth Björgvinsson, Thröstur oth Enthalten in Elsevier González, W. ELSEVIER Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study 2016 Amsterdam [u.a.] (DE-627)ELV014436809 volume:45 year:2014 number:2 pages:232-240 extent:9 https://doi.org/10.1016/j.beth.2013.11.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 35.21 Lösungen Flüssigkeiten Physikalische Chemie VZ AR 45 2014 2 232-240 9 045F 150 |
spelling |
10.1016/j.beth.2013.11.002 doi GBVA2014019000028.pica (DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 DE-627 ger DE-627 rakwb eng 150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl McHugh, R. Kathryn verfasserin aut Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting 2014transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Kertz, Sarah J. oth Weiss, Rachel B. oth Baskin-Sommers, Arielle R. oth Hearon, Bridget A. oth Björgvinsson, Thröstur oth Enthalten in Elsevier González, W. ELSEVIER Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study 2016 Amsterdam [u.a.] (DE-627)ELV014436809 volume:45 year:2014 number:2 pages:232-240 extent:9 https://doi.org/10.1016/j.beth.2013.11.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 35.21 Lösungen Flüssigkeiten Physikalische Chemie VZ AR 45 2014 2 232-240 9 045F 150 |
allfields_unstemmed |
10.1016/j.beth.2013.11.002 doi GBVA2014019000028.pica (DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 DE-627 ger DE-627 rakwb eng 150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl McHugh, R. Kathryn verfasserin aut Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting 2014transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Kertz, Sarah J. oth Weiss, Rachel B. oth Baskin-Sommers, Arielle R. oth Hearon, Bridget A. oth Björgvinsson, Thröstur oth Enthalten in Elsevier González, W. ELSEVIER Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study 2016 Amsterdam [u.a.] (DE-627)ELV014436809 volume:45 year:2014 number:2 pages:232-240 extent:9 https://doi.org/10.1016/j.beth.2013.11.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 35.21 Lösungen Flüssigkeiten Physikalische Chemie VZ AR 45 2014 2 232-240 9 045F 150 |
allfieldsGer |
10.1016/j.beth.2013.11.002 doi GBVA2014019000028.pica (DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 DE-627 ger DE-627 rakwb eng 150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl McHugh, R. Kathryn verfasserin aut Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting 2014transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Kertz, Sarah J. oth Weiss, Rachel B. oth Baskin-Sommers, Arielle R. oth Hearon, Bridget A. oth Björgvinsson, Thröstur oth Enthalten in Elsevier González, W. ELSEVIER Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study 2016 Amsterdam [u.a.] (DE-627)ELV014436809 volume:45 year:2014 number:2 pages:232-240 extent:9 https://doi.org/10.1016/j.beth.2013.11.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 35.21 Lösungen Flüssigkeiten Physikalische Chemie VZ AR 45 2014 2 232-240 9 045F 150 |
allfieldsSound |
10.1016/j.beth.2013.11.002 doi GBVA2014019000028.pica (DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 DE-627 ger DE-627 rakwb eng 150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl McHugh, R. Kathryn verfasserin aut Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting 2014transfer abstract 9 nicht spezifiziert zzz rdacontent nicht spezifiziert z rdamedia nicht spezifiziert zu rdacarrier Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. Kertz, Sarah J. oth Weiss, Rachel B. oth Baskin-Sommers, Arielle R. oth Hearon, Bridget A. oth Björgvinsson, Thröstur oth Enthalten in Elsevier González, W. ELSEVIER Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study 2016 Amsterdam [u.a.] (DE-627)ELV014436809 volume:45 year:2014 number:2 pages:232-240 extent:9 https://doi.org/10.1016/j.beth.2013.11.002 Volltext GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 35.21 Lösungen Flüssigkeiten Physikalische Chemie VZ AR 45 2014 2 232-240 9 045F 150 |
language |
English |
source |
Enthalten in Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study Amsterdam [u.a.] volume:45 year:2014 number:2 pages:232-240 extent:9 |
sourceStr |
Enthalten in Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study Amsterdam [u.a.] volume:45 year:2014 number:2 pages:232-240 extent:9 |
format_phy_str_mv |
Article |
bklname |
Lösungen Flüssigkeiten |
institution |
findex.gbv.de |
dewey-raw |
150 |
isfreeaccess_bool |
false |
container_title |
Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |
authorswithroles_txt_mv |
McHugh, R. Kathryn @@aut@@ Kertz, Sarah J. @@oth@@ Weiss, Rachel B. @@oth@@ Baskin-Sommers, Arielle R. @@oth@@ Hearon, Bridget A. @@oth@@ Björgvinsson, Thröstur @@oth@@ |
publishDateDaySort_date |
2014-01-01T00:00:00Z |
hierarchy_top_id |
ELV014436809 |
dewey-sort |
3150 |
id |
ELV034204075 |
language_de |
englisch |
fullrecord |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034204075</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625200208.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.beth.2013.11.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014019000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034204075</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0005-7894(13)00103-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">150</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.21</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McHugh, R. Kathryn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kertz, Sarah J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiss, Rachel B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baskin-Sommers, Arielle R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hearon, Bridget A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Björgvinsson, Thröstur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">González, W. ELSEVIER</subfield><subfield code="t">Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV014436809</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:232-240</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.beth.2013.11.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.21</subfield><subfield code="j">Lösungen</subfield><subfield code="j">Flüssigkeiten</subfield><subfield code="x">Physikalische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">232-240</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">150</subfield></datafield></record></collection>
|
author |
McHugh, R. Kathryn |
spellingShingle |
McHugh, R. Kathryn ddc 150 ddc 610 ddc 540 bkl 35.21 Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
authorStr |
McHugh, R. Kathryn |
ppnlink_with_tag_str_mv |
@@773@@(DE-627)ELV014436809 |
format |
electronic Article |
dewey-ones |
150 - Psychology 610 - Medicine & health 540 - Chemistry & allied sciences |
delete_txt_mv |
keep |
author_role |
aut |
collection |
elsevier |
remote_str |
true |
illustrated |
Not Illustrated |
topic_title |
150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
topic |
ddc 150 ddc 610 ddc 540 bkl 35.21 |
topic_unstemmed |
ddc 150 ddc 610 ddc 540 bkl 35.21 |
topic_browse |
ddc 150 ddc 610 ddc 540 bkl 35.21 |
format_facet |
Elektronische Aufsätze Aufsätze Elektronische Ressource |
format_main_str_mv |
Text Zeitschrift/Artikel |
carriertype_str_mv |
zu |
author2_variant |
s j k sj sjk r b w rb rbw a r b s arb arbs b a h ba bah t b tb |
hierarchy_parent_title |
Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |
hierarchy_parent_id |
ELV014436809 |
dewey-tens |
150 - Psychology 610 - Medicine & health 540 - Chemistry |
hierarchy_top_title |
Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |
isfreeaccess_txt |
false |
familylinks_str_mv |
(DE-627)ELV014436809 |
title |
Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
ctrlnum |
(DE-627)ELV034204075 (ELSEVIER)S0005-7894(13)00103-2 |
title_full |
Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
author_sort |
McHugh, R. Kathryn |
journal |
Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |
journalStr |
Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study |
lang_code |
eng |
isOA_bool |
false |
dewey-hundreds |
100 - Philosophy & psychology 600 - Technology 500 - Science |
recordtype |
marc |
publishDateSort |
2014 |
contenttype_str_mv |
zzz |
container_start_page |
232 |
author_browse |
McHugh, R. Kathryn |
container_volume |
45 |
physical |
9 |
class |
150 610 150 DE-600 610 DE-600 540 VZ 35.21 bkl |
format_se |
Elektronische Aufsätze |
author-letter |
McHugh, R. Kathryn |
doi_str_mv |
10.1016/j.beth.2013.11.002 |
dewey-full |
150 610 540 |
title_sort |
changes in distress intolerance and treatment outcome in a partial hospital setting |
title_auth |
Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
abstract |
Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. |
abstractGer |
Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. |
abstract_unstemmed |
Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety. |
collection_details |
GBV_USEFLAG_U GBV_ELV SYSFLAG_U SSG-OLC-PHA GBV_ILN_22 GBV_ILN_40 GBV_ILN_73 |
container_issue |
2 |
title_short |
Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting |
url |
https://doi.org/10.1016/j.beth.2013.11.002 |
remote_bool |
true |
author2 |
Kertz, Sarah J. Weiss, Rachel B. Baskin-Sommers, Arielle R. Hearon, Bridget A. Björgvinsson, Thröstur |
author2Str |
Kertz, Sarah J. Weiss, Rachel B. Baskin-Sommers, Arielle R. Hearon, Bridget A. Björgvinsson, Thröstur |
ppnlink |
ELV014436809 |
mediatype_str_mv |
z |
isOA_txt |
false |
hochschulschrift_bool |
false |
author2_role |
oth oth oth oth oth |
doi_str |
10.1016/j.beth.2013.11.002 |
up_date |
2024-07-06T20:31:55.775Z |
_version_ |
1803863107333783552 |
fullrecord_marcxml |
<?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01000caa a22002652 4500</leader><controlfield tag="001">ELV034204075</controlfield><controlfield tag="003">DE-627</controlfield><controlfield tag="005">20230625200208.0</controlfield><controlfield tag="007">cr uuu---uuuuu</controlfield><controlfield tag="008">180603s2014 xx |||||o 00| ||eng c</controlfield><datafield tag="024" ind1="7" ind2=" "><subfield code="a">10.1016/j.beth.2013.11.002</subfield><subfield code="2">doi</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">GBVA2014019000028.pica</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-627)ELV034204075</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(ELSEVIER)S0005-7894(13)00103-2</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-627</subfield><subfield code="b">ger</subfield><subfield code="c">DE-627</subfield><subfield code="e">rakwb</subfield></datafield><datafield tag="041" ind1=" " ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">150</subfield><subfield code="a">610</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">150</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">610</subfield><subfield code="q">DE-600</subfield></datafield><datafield tag="082" ind1="0" ind2="4"><subfield code="a">540</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">35.21</subfield><subfield code="2">bkl</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">McHugh, R. Kathryn</subfield><subfield code="e">verfasserin</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Changes in Distress Intolerance and Treatment Outcome in a Partial Hospital Setting</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="c">2014transfer abstract</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">9</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zzz</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">z</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="a">nicht spezifiziert</subfield><subfield code="b">zu</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety.</subfield></datafield><datafield tag="520" ind1=" " ind2=" "><subfield code="a">Despite the well-established role of distress intolerance (DI) in a wide range of psychological disorders, few studies have examined whether DI improves during treatment and whether these changes are associated with symptom outcomes. Patients (N =626) enrolled in a brief cognitive-behavioral partial hospital program completed pre- and posttreatment measures of DI. Results indicated that DI decreased significantly during treatment, with more than 30% of the sample exhibiting a reduction of more than 2 standard deviations from the sample mean. Women reported higher DI than men at baseline; however, there were no gender differences in changes in DI over time. Participants also completed a pre- and posttreatment measure of depression and a subset completed a measure of anxiety (n =167). DI was associated with more severe depression and anxiety at pre- and posttreatment, with participants who reported a decrease in DI also reporting lower depression and anxiety symptoms at post-treatment. These results further highlight the transdiagnostic relevance of DI and suggest that DI may be a relevant factor in treatment outcome for depression and anxiety.</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Kertz, Sarah J.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Weiss, Rachel B.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Baskin-Sommers, Arielle R.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Hearon, Bridget A.</subfield><subfield code="4">oth</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Björgvinsson, Thröstur</subfield><subfield code="4">oth</subfield></datafield><datafield tag="773" ind1="0" ind2="8"><subfield code="i">Enthalten in</subfield><subfield code="n">Elsevier</subfield><subfield code="a">González, W. ELSEVIER</subfield><subfield code="t">Carbon and oxigen minibeam radiation therapy: A Monte Carlo dosimetry study</subfield><subfield code="d">2016</subfield><subfield code="g">Amsterdam [u.a.]</subfield><subfield code="w">(DE-627)ELV014436809</subfield></datafield><datafield tag="773" ind1="1" ind2="8"><subfield code="g">volume:45</subfield><subfield code="g">year:2014</subfield><subfield code="g">number:2</subfield><subfield code="g">pages:232-240</subfield><subfield code="g">extent:9</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">https://doi.org/10.1016/j.beth.2013.11.002</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_USEFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ELV</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SYSFLAG_U</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">SSG-OLC-PHA</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_22</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_40</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">GBV_ILN_73</subfield></datafield><datafield tag="936" ind1="b" ind2="k"><subfield code="a">35.21</subfield><subfield code="j">Lösungen</subfield><subfield code="j">Flüssigkeiten</subfield><subfield code="x">Physikalische Chemie</subfield><subfield code="q">VZ</subfield></datafield><datafield tag="951" ind1=" " ind2=" "><subfield code="a">AR</subfield></datafield><datafield tag="952" ind1=" " ind2=" "><subfield code="d">45</subfield><subfield code="j">2014</subfield><subfield code="e">2</subfield><subfield code="h">232-240</subfield><subfield code="g">9</subfield></datafield><datafield tag="953" ind1=" " ind2=" "><subfield code="2">045F</subfield><subfield code="a">150</subfield></datafield></record></collection>
|
score |
7.4003134 |